Company intelligence / Profile preview

Takis Biotech

Ownership: Private
Employees: ~200
Development stage: Preclinical

Overview

Takis is focused on developing innovative immunotherapies, particularly therapeutic cancer vaccines targeting tumor antigens. The company has also developed a linear DNA vaccine candidate for coronavirus and is engaged in biomarker discovery and molecular diagnostics. Its proprietary gene-electro-transfer platform enhances the efficacy of nucleic acid-based therapies by improving tissue uptake and immune response. Clinical results are primarily preclinical with ongoing collaborations to advance candidates into clinical trials[1][3][5].

Therapeutic areas: OncologyInfectious Diseases
Modalities: Cancer vaccines (therapeutic)DNA vaccines (including linear DNA vaccines)Gene delivery technologies (notably gene-electro-transfer/EGT)
Industry: Biotech

Drug pipeline

3 assets

TK002

Preclinical

2 more assets in the full pipeline.

Partnerships

Academic partners for drug effectiveness studies and biomarker discovery[5]Industrial partners/joint ventures for diagnostic test development and infectious disease vaccines[3]

Beyond the preview

Go deeper on Takis Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Takis Biotech.